Head-to-head · WeighScore
OrderlyMeds vs Sunlight.com
The verdict
Sunlight.com takes it — 85.4/100 to 67/100.
Sunlight.com grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the cheapest published rates in the ranking — semaglutide $88/mo, tirzepatide $157/mo, flat and stated never to rise — from a LegitScript-certified telehealth with two named, NPI-verified physicians.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | OrderlyMeds | Sunlight.com |
|---|---|---|
| WeighScore | 67/100 | 85.4/100 |
| Grade | C | B |
| Scorecard rank | #167 | #7 |
| Semaglutide | $74/mo (starting dose, 2-mo starter plan, new patients only, compounded) | $88/mo |
| Tirzepatide | $299/mo (compounded) | $157/mo |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #167 · C
FDAWarning letter issued to OrderlyMeds LLC dba OrderlyMeds in June 2026. See the FDA warning-letter database.
Strengths
- The starter rate and the standing rate are both published, so the step-up is visible before signing up
- No membership fees and no hidden costs, stated as such
- The dose ladder is published: four weeks at 0.25 mg then four weeks at 0.5 mg
- Brand-name routes are priced openly, at retail
Where it loses points
- The $74 rate is a two-month starter plan billed as $149 up front, and it is open only to patients new to GLP-1 medication; the standing monthly rate is $149
- Tirzepatide has no equivalent standing discount — $299/mo is the ongoing rate
- Brand-name routes are priced at retail: Wegovy $1,839 and Zepbound $1,498
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
- FDA issued OrderlyMeds LLC dba OrderlyMeds a warning letter in June 2026; the letter is public in FDA's warning-letter database
Graded #7 · B
Strengths
- Cheapest published semaglutide in this ranking ($88/mo) with competitively priced tirzepatide ($157/mo), both flat and stated to never increase — not quiz-gated, the FAQ states the exact figures
- LegitScript-certified with two named physicians and public NPI numbers (Lion MD network), rather than an anonymous "licensed clinicians" claim
- No membership fee, cancel anytime, free shipping in 1-2 days, a fresh 4-week supply every month
- All 50 states served, plus a separate live NAD+ program on the same domain
Where it loses points
- Injection only — the hero banner's "Injections and oral options available" line does not match the live site: no oral GLP-1 product page exists and sunlight.com/oral-semaglutide/ 404s
- The $157 tirzepatide figure sits inside a collapsed FAQ accordion rather than the hero, so it takes one extra click to find even though it is genuinely on the page
- Sermorelin is marketed as "launching soon" and is not yet live — do not expect it today
- No published lab or monitoring cadence, and the compounding pharmacy partner is referenced only generically, not named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 509 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.